Petmed Express Inc logo

PETS - Petmed Express Inc Share Price

$31.88 0.3  0.8%

Last Trade - 9:00pm

Consumer Defensives
Mid Cap
Market Cap £487.6m
Enterprise Value £421.6m
Revenue £228.5m
Position in Universe 2695th / 6362
Unlock PETS Revenue
Relative Strength (%)
1m -18.9%
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -26.3%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Mar 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
229.4 234.7 249.2 273.8 283.4 284.1 310.6 323.1 +4.4%
+2.6 +10.4 +15.1 +45.7 +8.1 -30.0 +17.5 +8.84
Balance Sheet
FINANCIAL BRIEF: : For the three months ended 30 June 2020, Petmed Express Inc revenues increased 20% to $96.2M. Net income increased 45% to $7.8M. Revenues reflect Sales - Internet sales increase of 19% to $80.4M. Net income benefited from Depreciation decrease of 1% to $562K (expense). Dividend per share increased from $0.27 to $0.28. Basic Earnings per Share excluding Extraordinary Items increased from $0.26 to $0.39.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Latest News & Insights for PETS
Graphical History


PETS Revenue Unlock PETS Revenue

Net Income

PETS Net Income Unlock PETS Revenue

Normalised EPS

PETS Normalised EPS Unlock PETS Revenue

PE Ratio Range

PETS PE Ratio Range Unlock PETS Revenue

Dividend Yield Range

PETS Dividend Yield Range Unlock PETS Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
PETS EPS Forecasts Unlock PETS Revenue
Profile Summary

PetMed Express, Inc. (PetMed Express), doing business as 1800PetMeds, is a pet pharmacy. The Company markets prescription and non-prescription pet medications, and other health products for dogs and cats, direct to the consumer. It offers a selection of products for dogs and cats. Its product line contains approximately 3,000 stock keeping units (SKUS) of pet medications, health products and supplies. Its products include brands of medication, such as Frontline Plus, K9 Advantix II, Advantage II, Heartgard Plus, Sentinel, Revolution and Rimadyl. It also offers additional pet supplies for sale on its Website, which are drop shipped to its customers by third parties. These pet supplies include food, beds, crates, stairs, strollers and other pet supplies. Its products included Non-Prescription Medications (Over the Counter (OTC)) and supplies, and Prescription Medications (Rx). Its customers are located in California, Florida, Texas, New York, Virginia and Georgia, among others.

Last Annual March 31st, 2020
Last Interim June 30th, 2020
Incorporated January 29, 1996
Public Since January 11, 1999
No. of Shareholders: 30,700
No. of Employees: 214
Sector Consumer Defensives
Industry Food & Drug Retailing
Index Nasdaq Composite , S&P 600 Small Cap , S&P Composite 1500 ,
Exchange NASDAQ Global Select Market
Shares in Issue 20,272,072
Free Float (0.0%)
Eligible for
PETS Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for PETS
Upcoming Events for PETS
Monday 19th October, 2020 Estimate
Q2 2020 Petmed Express Inc Earnings Release
Tuesday 19th January, 2021 Estimate
Q3 2020 Petmed Express Inc Earnings Release
Frequently Asked Questions for Petmed Express Inc
What is the Petmed Express Inc share price?

As of 9:00pm, shares in Petmed Express Inc are trading at $31.88, giving the company a market capitalisation of £487.6m. This share price information is delayed by 15 minutes.

How has the Petmed Express Inc share price performed this year?

Shares in Petmed Express Inc are currently trading at $31.88 and the price has moved by 85.56% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Petmed Express Inc price has moved by 63.83% over the past year.

What are the analyst and broker recommendations for Petmed Express Inc?

Of the analysts with advisory recommendations for Petmed Express Inc, there are there are currently 0 "buy" , 1 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Petmed Express Inc is Sell. You can view the full broker recommendation list by unlocking its StockReport.

When will Petmed Express Inc next release its financial results?

Petmed Express Inc is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-06-30
What is the Petmed Express Inc dividend yield?

The Petmed Express Inc dividend yield is 3.45% based on the trailing twelve month period.

Does Petmed Express Inc pay a dividend?

Last year, Petmed Express Inc paid a total dividend of 1.09, and it currently has a trailing dividend yield of 3.45%. Looking ahead, Petmed Express Inc has not announced an ex-dividend date yet and the next dividend pay date is 2020-08-07.

When does Petmed Express Inc next pay dividends?

Petmed Express Inc has yet to annouce their ex-dividend date and the next dividend pay date is 2020-08-07. The historic dividend yield on Petmed Express Inc shares is currently 3.45%.

How do I buy Petmed Express Inc shares?

To buy shares in Petmed Express Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Petmed Express Inc?

Shares in Petmed Express Inc are currently trading at $31.88, giving the company a market capitalisation of £487.6m.

Where are Petmed Express Inc shares listed? Where are Petmed Express Inc shares listed?

Here are the trading details for Petmed Express Inc:

Country of listing: United States
Exchange: NSQ
Ticker Symbol: PETS
What kind of share is Petmed Express Inc?

Based on an overall assessment of its quality, value and momentum, Petmed Express Inc is currently classified as a Style Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Petmed Express Inc share price forecast 2020?

Shares in Petmed Express Inc are currently priced at $31.88. At that level they are trading at 9.87% premium to the analyst consensus target price of 0.00.

Analysts covering Petmed Express Inc currently have a consensus Earnings Per Share (EPS) forecast of 1.515 for the next financial year.

How can I tell whether the Petmed Express Inc share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Petmed Express Inc. Over the past six months, the relative strength of its shares against the market has been 16.2%. At the current price of $31.88, shares in Petmed Express Inc are trading at 7.96% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Petmed Express Inc PE Ratio?

The Petmed Express Inc PE ratio based on its reported earnings over the past 12 months is 22.33. The shares are currently trading at $31.88.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of Petmed Express Inc?

Petmed Express Inc's management team is headed by:

Menderes Akdag - CEO
Bruce Rosenbloom - CFO
Robert Schweitzer - CHM
Ronald Korn - IND
Gian Fulgoni - IND
Frank Formica - IND
Leslie Campbell - IND
Who are the major shareholders of Petmed Express Inc?

Here are the top five shareholders of Petmed Express Inc based on the size of their shareholding:

BlackRock Institutional Trust Company, N.A. Investment Advisor
Percentage owned: 13.95% (2.83m shares)
Renaissance Technologies LLC Hedge Fund
Percentage owned: 7.96% (1.61m shares)
The Vanguard Group, Inc. Investment Advisor/Hedge Fund
Percentage owned: 6.96% (1.41m shares)
iShares Core S&P Small-Cap ETF Mutual Fund
Percentage owned: 6.21% (1.26m shares)
State Street Global Advisors (US) Investment Advisor/Hedge Fund
Percentage owned: 4.11% (834k shares)
Similar to PETS
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.